Bill Clinton Hospitalized; Lower Cost Ozempic? WHO Withdrawal Planned Health news and commentary gathered by 番茄社区app staff Dec 24, 2024
First Generic of Once-Daily GLP-1 Injection Approved for Diabetes Generic liraglutide approved at dosage for type 2 diabetes only Dec 23, 2024
FDA Says Compounded Tirzepatide Must Exit the Market Compounders only have 2 to 3 months left to copy injectable Dec 19, 2024
Recalled Pacemakers; FDA Rejects Full Andexxa Approval; Ticagrelor Back in Hot Seat Recent developments of interest in cardiovascular medicine Dec 17, 2024
Newer Diabetes Drugs Still Under-Prescribed in High-Risk Patients Cost, insurance coverage likely play outsized role Dec 16, 2024
HEARTS Act Gets Senate Vote; New Myocarditis Classes; Aftermath of PAD Device Scare Recent developments of interest in cardiovascular medicine Dec 10, 2024
Empathetic Phone Calls Help Vulnerable Diabetes Patients Lower HbA1c Social support may be key to improving glycemic control, experts say Dec 10, 2024
Are GLP-1 Drug Holidays a Risk Worth Taking? Experts weigh in on weight regain, cardiometabolic fallout, and the future of tailored care Dec 08, 2024 video
GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots 20% lower risk of VTE observed in large retrospective study of diabetes patients Dec 08, 2024
Women's CVD Risk Calculations Barely Budge When Sex-Specific Variables Are Included Existing models improved only slightly after accounting for certain female risk factors Dec 06, 2024
FDA Panned at Senate Hearing for Failure to Address Diabetes, Obesity Epidemics Agency has failed to hold food manufacturers accountable, said Sen. Bernie Sanders Dec 05, 2024
Empagliflozin Linked to Lower Risk of Diabetic Retinopathy Progression But the drug didn't appear to lower the risk of incident nonproliferative diabetic retinopathy Dec 05, 2024
Untangling GLP-1 Risks: Are Side Effects Overblown? Experts tackle myths, data bias, and game-changing outcomes of obesity drugs Dec 05, 2024 video
New Study Teases Out Chocolate and Diabetes Connection Eating more dark chocolate was associated with a lower risk of type 2 diabetes Dec 04, 2024
Tirzepatide Tops Semaglutide for Weight Loss in Head-to-Head Trial, Eli Lilly Says Dual GLP-1/GIP drug yielded an average 47% greater relative weight loss compared to semaglutide Dec 04, 2024
GLP-1s: The Medications Redefining Diabetes and Obesity Treatment Experts tackle access, equity, and the blockbuster drugs reshaping healthcare Dec 04, 2024 video
Timelier U.S. Guidelines; Spouse's Personality & CVD; 'Hostile' Cardiologists Out Recent developments of interest in cardiovascular medicine Dec 03, 2024
Hunting & Heart Attacks; Cardiologist's Whistleblower Suit; Algorithm Predicts Death Recent developments of interest in cardiovascular medicine Nov 26, 2024
Many Drinkers Cut Back After Starting Obesity Meds, Study Finds In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug Nov 26, 2024
CGM Uptake Very Low for Vulnerable Diabetes Populations But how to achieve equitable use remains "complicated," says expert Nov 22, 2024
GLP-1 Use Prior to Surgery: Analyzing the Updated Guidance Balancing aspiration risk with the consequences of medication discontinuation Nov 20, 2024
More Lp(a)-Reducing Tx; Cardiac Denervation for Afib; LAA Occluders at 5 Years Recent developments of interest in cardiovascular medicine Nov 19, 2024
Over 50% of U.S. Adults Qualify for Ozempic, Wegovy Most are eligible for weight management indication Nov 18, 2024
Tirzepatide Officially Puts GLP-1 Meds on the Map for Heart Failure Benefit SUMMIT trial able to show clinical benefit beyond quality-of-life improvement Nov 16, 2024
Multiple Chronic Conditions and Death; Diabetes Treatment for Gout Also in TTHealthWatch: frailty as a predictor of dementia Nov 16, 2024 podcast
GLP-1 Drugs Could Help People With Alcohol Use Disorder Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations Nov 13, 2024
Post-Pandemic OHCA Survival Down; Vitamin D Supplements & BP; Varipulse PFA Approved Recent developments of interest in cardiovascular medicine Nov 12, 2024
Who Needs a Defibrillator After MI? FDA Recs on Inferior Vena Cava Filters Also in TTHealthWatch: early sugar exposure, hypertension, and diabetes Nov 09, 2024 podcast
Nurse's Death Tied to GLP-1 Drug; Research Monkey Jailbreak; Congressman Has Cancer Health news and commentary gathered by 番茄社区app staff Nov 08, 2024
Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Years Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist Nov 07, 2024
Early-Life Sugar Restriction Reduced Diabetes, Hypertension Risk Diagnoses were also delayed the longer sugar was restricted Nov 06, 2024
Do GLP-1 Agonists Really Need to Be Stopped Before Endoscopy? Meta-analysis suggests 24-hour clear liquid diet works to avoid aspiration, even with GLP-1s Nov 05, 2024
ASA Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most Patients New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents Oct 30, 2024
Cold Weather Heart Attacks; Preemptive Valve Procedures Flop; Better Bleeding Score Recent developments of interest in cardiovascular medicine Oct 29, 2024
No Kidney Benefit With Finerenone in Heart Failure Patients Anti-mineralocorticoid agent reduced albuminuria, but not eGFR-based kidney outcome Oct 28, 2024
Ozempic Linked With Lower Risk of Alzheimer's Diagnosis Large observational study suggests further research is warranted Oct 24, 2024
Scripts for GLP-1, SGLT2 Drugs on the Rise in Type 1 Diabetes Patients Findings leave researcher "concerned" Oct 23, 2024
